Pillenschlacht um Milliarden: Merck, Glaxo und die Pharmaindustrie
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Language: | German |
| Published: |
Frankfurt [u.a.]
Campus-Verl.
1993
|
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | 232 S. |
| ISBN: | 3593349523 |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV008181307 | ||
| 003 | DE-604 | ||
| 005 | 19970312 | ||
| 007 | t | ||
| 008 | 930816s1993 gw |||| 00||| ger d | ||
| 020 | |a 3593349523 |9 3-593-34952-3 | ||
| 035 | |a (OCoLC)231559696 | ||
| 035 | |a (DE-599)BVBBV008181307 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a ger | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-355 |a DE-473 |a DE-12 |a DE-703 |a DE-20 |a DE-210 |a DE-83 |a DE-11 |a DE-188 |a DE-578 | ||
| 084 | |a MS 6000 |0 (DE-625)123738: |2 rvk | ||
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 084 | |a VB 4010 |0 (DE-625)147021:253 |2 rvk | ||
| 100 | 1 | |a Lynn, Matthew |e Verfasser |4 aut | |
| 240 | 1 | 0 | |a The billion dollar battle |
| 245 | 1 | 0 | |a Pillenschlacht um Milliarden |b Merck, Glaxo und die Pharmaindustrie |c Matthew Lynn |
| 264 | 1 | |a Frankfurt [u.a.] |b Campus-Verl. |c 1993 | |
| 300 | |a 232 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 610 | 2 | 7 | |a Glaxo Group Research Limited |0 (DE-588)4321697-3 |2 gnd |9 rswk-swf |
| 610 | 2 | 7 | |a F. Hoffmann-La Roche AG |0 (DE-588)2118013-1 |2 gnd |9 rswk-swf |
| 610 | 2 | 7 | |a Merck & Co. |0 (DE-588)5284383-X |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Strategisches Management |0 (DE-588)4124261-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Internationaler Wettbewerb |0 (DE-588)4027415-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Geschichte |0 (DE-588)4020517-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Marketing |0 (DE-588)4037589-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wettbewerb |0 (DE-588)4065835-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Wettbewerb |0 (DE-588)4065835-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 1 | 1 | |a Marketing |0 (DE-588)4037589-4 |D s |
| 689 | 1 | 2 | |a Strategisches Management |0 (DE-588)4124261-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a F. Hoffmann-La Roche AG |0 (DE-588)2118013-1 |D b |
| 689 | 2 | 1 | |a Geschichte |0 (DE-588)4020517-4 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a Merck & Co. |0 (DE-588)5284383-X |D b |
| 689 | 3 | 1 | |a Geschichte |0 (DE-588)4020517-4 |D s |
| 689 | 3 | |5 DE-604 | |
| 689 | 4 | 0 | |a Glaxo Group Research Limited |0 (DE-588)4321697-3 |D b |
| 689 | 4 | 1 | |a Geschichte |0 (DE-588)4020517-4 |D s |
| 689 | 4 | |5 DE-604 | |
| 689 | 5 | 0 | |a Internationaler Wettbewerb |0 (DE-588)4027415-9 |D s |
| 689 | 5 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 5 | |5 DE-604 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005399488&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005399488 | ||
Record in the Search Index
| _version_ | 1804122566454935552 |
|---|---|
| adam_text | Inhalt
Danksagung 7
Anmerkung des Autors 8
Vorwort zur deutschen Ausgabe 9
Einführung: Das Molekülkasino 13
Teill
Der Ursprung: Hoffmann La Röche
1 Die Unternehmer von Basel 35
2 Valiumanie 50
3 Jagd auf Hoffmann La Röche 59
Teil 2
Der Aristokrat: Merck
4 Eine andere Tomate in einem anderen Sandwich 79
5 Von Darmstadt nach Rahway 85
6 Von Machenschaften und Manipulationen 97
7 Der Rationalist 105
8 Forscher oder Spinner? 118
9 Präzisionsarbeit 127
10 Der Hofstaat des Königs 134
11 Der König und seine Philosophie 139
Teil 3
Der Räuber: Glaxo
12 Ödland 155
13 Das »Bonny Baby« 163
14 Der große Erfinder 170
15 Der Zahlenmensch 177
16 Die Trumpfkarte 184
17 Krieg 193
18 Das Leben an der Spitze 200
19 Der Chef 209
Epilog: Zwei Konzerne, zwei Arzneien 217
|
| any_adam_object | 1 |
| author | Lynn, Matthew |
| author_facet | Lynn, Matthew |
| author_role | aut |
| author_sort | Lynn, Matthew |
| author_variant | m l ml |
| building | Verbundindex |
| bvnumber | BV008181307 |
| classification_rvk | MS 6000 QR 525 VB 4010 |
| ctrlnum | (OCoLC)231559696 (DE-599)BVBBV008181307 |
| discipline | Chemie / Pharmazie Soziologie Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02749nam a2200661 c 4500</leader><controlfield tag="001">BV008181307</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19970312 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">930816s1993 gw |||| 00||| ger d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3593349523</subfield><subfield code="9">3-593-34952-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)231559696</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008181307</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-473</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-210</subfield><subfield code="a">DE-83</subfield><subfield code="a">DE-11</subfield><subfield code="a">DE-188</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MS 6000</subfield><subfield code="0">(DE-625)123738:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VB 4010</subfield><subfield code="0">(DE-625)147021:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lynn, Matthew</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="240" ind1="1" ind2="0"><subfield code="a">The billion dollar battle</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pillenschlacht um Milliarden</subfield><subfield code="b">Merck, Glaxo und die Pharmaindustrie</subfield><subfield code="c">Matthew Lynn</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Frankfurt [u.a.]</subfield><subfield code="b">Campus-Verl.</subfield><subfield code="c">1993</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">232 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Glaxo Group Research Limited</subfield><subfield code="0">(DE-588)4321697-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">F. Hoffmann-La Roche AG</subfield><subfield code="0">(DE-588)2118013-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="610" ind1="2" ind2="7"><subfield code="a">Merck & Co.</subfield><subfield code="0">(DE-588)5284383-X</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Strategisches Management</subfield><subfield code="0">(DE-588)4124261-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Internationaler Wettbewerb</subfield><subfield code="0">(DE-588)4027415-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Geschichte</subfield><subfield code="0">(DE-588)4020517-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Marketing</subfield><subfield code="0">(DE-588)4037589-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wettbewerb</subfield><subfield code="0">(DE-588)4065835-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Wettbewerb</subfield><subfield code="0">(DE-588)4065835-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Marketing</subfield><subfield code="0">(DE-588)4037589-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Strategisches Management</subfield><subfield code="0">(DE-588)4124261-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">F. Hoffmann-La Roche AG</subfield><subfield code="0">(DE-588)2118013-1</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Geschichte</subfield><subfield code="0">(DE-588)4020517-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Merck & Co.</subfield><subfield code="0">(DE-588)5284383-X</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Geschichte</subfield><subfield code="0">(DE-588)4020517-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="4" ind2="0"><subfield code="a">Glaxo Group Research Limited</subfield><subfield code="0">(DE-588)4321697-3</subfield><subfield code="D">b</subfield></datafield><datafield tag="689" ind1="4" ind2="1"><subfield code="a">Geschichte</subfield><subfield code="0">(DE-588)4020517-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="4" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="5" ind2="0"><subfield code="a">Internationaler Wettbewerb</subfield><subfield code="0">(DE-588)4027415-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="5" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005399488&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005399488</subfield></datafield></record></collection> |
| id | DE-604.BV008181307 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T17:15:55Z |
| institution | BVB |
| isbn | 3593349523 |
| language | German |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005399488 |
| oclc_num | 231559696 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-473 DE-BY-UBG DE-12 DE-703 DE-20 DE-210 DE-83 DE-11 DE-188 DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-473 DE-BY-UBG DE-12 DE-703 DE-20 DE-210 DE-83 DE-11 DE-188 DE-578 |
| physical | 232 S. |
| publishDate | 1993 |
| publishDateSearch | 1993 |
| publishDateSort | 1993 |
| publisher | Campus-Verl. |
| record_format | marc |
| spelling | Lynn, Matthew Verfasser aut The billion dollar battle Pillenschlacht um Milliarden Merck, Glaxo und die Pharmaindustrie Matthew Lynn Frankfurt [u.a.] Campus-Verl. 1993 232 S. txt rdacontent n rdamedia nc rdacarrier Glaxo Group Research Limited (DE-588)4321697-3 gnd rswk-swf F. Hoffmann-La Roche AG (DE-588)2118013-1 gnd rswk-swf Merck & Co. (DE-588)5284383-X gnd rswk-swf Strategisches Management (DE-588)4124261-0 gnd rswk-swf Internationaler Wettbewerb (DE-588)4027415-9 gnd rswk-swf Geschichte (DE-588)4020517-4 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Marketing (DE-588)4037589-4 gnd rswk-swf Wettbewerb (DE-588)4065835-1 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 s Wettbewerb (DE-588)4065835-1 s DE-604 Marketing (DE-588)4037589-4 s Strategisches Management (DE-588)4124261-0 s F. Hoffmann-La Roche AG (DE-588)2118013-1 b Geschichte (DE-588)4020517-4 s Merck & Co. (DE-588)5284383-X b Glaxo Group Research Limited (DE-588)4321697-3 b Internationaler Wettbewerb (DE-588)4027415-9 s HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005399488&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Lynn, Matthew Pillenschlacht um Milliarden Merck, Glaxo und die Pharmaindustrie Glaxo Group Research Limited (DE-588)4321697-3 gnd F. Hoffmann-La Roche AG (DE-588)2118013-1 gnd Merck & Co. (DE-588)5284383-X gnd Strategisches Management (DE-588)4124261-0 gnd Internationaler Wettbewerb (DE-588)4027415-9 gnd Geschichte (DE-588)4020517-4 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Marketing (DE-588)4037589-4 gnd Wettbewerb (DE-588)4065835-1 gnd |
| subject_GND | (DE-588)4321697-3 (DE-588)2118013-1 (DE-588)5284383-X (DE-588)4124261-0 (DE-588)4027415-9 (DE-588)4020517-4 (DE-588)4045696-1 (DE-588)4037589-4 (DE-588)4065835-1 |
| title | Pillenschlacht um Milliarden Merck, Glaxo und die Pharmaindustrie |
| title_alt | The billion dollar battle |
| title_auth | Pillenschlacht um Milliarden Merck, Glaxo und die Pharmaindustrie |
| title_exact_search | Pillenschlacht um Milliarden Merck, Glaxo und die Pharmaindustrie |
| title_full | Pillenschlacht um Milliarden Merck, Glaxo und die Pharmaindustrie Matthew Lynn |
| title_fullStr | Pillenschlacht um Milliarden Merck, Glaxo und die Pharmaindustrie Matthew Lynn |
| title_full_unstemmed | Pillenschlacht um Milliarden Merck, Glaxo und die Pharmaindustrie Matthew Lynn |
| title_short | Pillenschlacht um Milliarden |
| title_sort | pillenschlacht um milliarden merck glaxo und die pharmaindustrie |
| title_sub | Merck, Glaxo und die Pharmaindustrie |
| topic | Glaxo Group Research Limited (DE-588)4321697-3 gnd F. Hoffmann-La Roche AG (DE-588)2118013-1 gnd Merck & Co. (DE-588)5284383-X gnd Strategisches Management (DE-588)4124261-0 gnd Internationaler Wettbewerb (DE-588)4027415-9 gnd Geschichte (DE-588)4020517-4 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Marketing (DE-588)4037589-4 gnd Wettbewerb (DE-588)4065835-1 gnd |
| topic_facet | Glaxo Group Research Limited F. Hoffmann-La Roche AG Merck & Co. Strategisches Management Internationaler Wettbewerb Geschichte Pharmazeutische Industrie Marketing Wettbewerb |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005399488&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT lynnmatthew thebilliondollarbattle AT lynnmatthew pillenschlachtummilliardenmerckglaxounddiepharmaindustrie |